These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6259300)

  • 1. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.
    Mortimer JE; Hewlett JS; Bay J; Livingston RB
    J Neurooncol; 1983; 1(3):269-73. PubMed ID: 6088718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP
    J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
    Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ
    Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone-marrow transplantation: host effects of high-dose BCNU.
    Takvorian T; Parker LM; Hochberg FH; Canellos GP
    J Clin Oncol; 1983 Oct; 1(10):610-20. PubMed ID: 6366127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
    Phillips GL; Wolff SN; Fay JW; Herzig RH; Lazarus HM; Schold C; Herzig GP
    J Clin Oncol; 1986 May; 4(5):639-45. PubMed ID: 3009725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing management of the patient receiving high-dose BCNU with autologous bone marrow harvest.
    Gamel-Bentzel C
    J Neurosurg Nurs; 1982 Apr; 14(2):98-102. PubMed ID: 6288899
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
    Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
    Hochberg FH; Pruitt AA; Beck DO; DeBrun G; Davis K
    J Neurosurg; 1985 Dec; 63(6):876-80. PubMed ID: 2997415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clonogenic human brain tumour cells: preliminary results of tumour sensitivity testing with BCNU.
    Rosenblum ML; Dougherty DA; Deen DF; Hoshino T; Wilson CB
    Br J Cancer Suppl; 1980 Apr; 4():181-5. PubMed ID: 6252931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
    Bashir R; Hochberg FH; Linggood RM; Hottleman K
    J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
    Levin VA; Hoffman WF; Pischer TL; Seager ML; Boldrey EB; Wilson CB
    Cancer Treat Rep; 1978 Dec; 62(12):2071-6. PubMed ID: 221113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of patients treated with BCNU for brain tumors.
    Calogero J; Crafts DC; Wilson CB; Boldrey EB; Rosenberg A; Enot KJ
    J Neurosurg; 1975 Aug; 43(2):191-6. PubMed ID: 1185250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early pulmonary toxicity after administration of high-dose BCNU.
    Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
    Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility study of combining metronidazole with chemotherapy.
    Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
    J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
    Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
    J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.
    Wolff SN; Phillips GL; Herzig GP
    Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease.
    Ahmed T; Ciavarella D; Feldman E; Ascensao J; Hussain F; Engelking C; Gingrich S; Mittelman A; Coleman M; Arlin ZA
    Leukemia; 1989 Jan; 3(1):19-22. PubMed ID: 2642573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.